2 Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
Arch Med Sci. 2011 Dec 31;7(6):1067-75. doi: 10.5114/aoms.2011.26621. Epub 2011 Dec 30.
Cardiovascular disease (CVD) is common in patients with diabetes mellitus (DM) and related clinical outcomes are worse compared with non-diabetics. The optimal treatment in diabetic patients with coronary heart disease (CHD) is currently not established. We searched MEDLINE (1975-2010) using the key terms diabetes mellitus, coronary heart disease, revascularization, coronary artery bypass, angioplasty, coronary intervention and medical treatment. Most studies comparing different revascularization procedures in patients with CHD favoured coronary artery bypass graft (CABG) surgery in patients with DM. However, most of this evidence comes from subgroup analyses. Recent evidence suggests that advanced percutaneous coronary intervention (PCI) techniques along with best medical treatment may be non-inferior and more cost-effective compared with CABG. Treatment of vascular risk factors is a key option in terms of improving CVD outcomes in diabetic patients with CHD. The choice between medical therapy and revascularization warrants further assessment.
心血管疾病(CVD)在糖尿病(DM)患者中很常见,与非糖尿病患者相比,其临床预后更差。目前,对于患有冠心病(CHD)的糖尿病患者,最佳治疗方法尚未确定。我们使用糖尿病、冠心病、血运重建、冠状动脉旁路移植术、血管成形术、冠状动脉介入治疗和药物治疗等关键词在 MEDLINE(1975-2010 年)进行了检索。大多数比较不同血运重建程序在 CHD 患者中的研究结果都倾向于在 DM 患者中采用冠状动脉旁路移植术(CABG)。然而,这些证据大多来自亚组分析。最近的证据表明,与 CABG 相比,先进的经皮冠状动脉介入治疗(PCI)技术联合最佳药物治疗可能具有非劣效性和更高的成本效益。治疗血管危险因素是改善 CHD 合并糖尿病患者 CVD 结局的关键选择。药物治疗与血运重建之间的选择需要进一步评估。